BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan SU, Singh M, Valavoor S, Khan MU, Lone AN, Khan MZ, Khan MS, Mani P, Kapadia SR, Michos ED, Stone GW, Kalra A, Bhatt DL. Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis. Circulation 2020;142:1425-36. [PMID: 32795096 DOI: 10.1161/CIRCULATIONAHA.120.046308] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 van der Sangen NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, Windecker S, James SK, Buccheri S, Ten Berg JM, Henriques JPS, Voskuil M, Kikkert WJ. Patient-tailored antithrombotic therapy following percutaneous coronary intervention. Eur Heart J 2021;42:1038-46. [PMID: 33515031 DOI: 10.1093/eurheartj/ehaa1097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wiebe J, Ndrepepa G, Kufner S, Lahmann AL, Xhepa E, Kuna C, Voll F, Gosetti R, Laugwitz KL, Joner M, Kastrati A, Cassese S. Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2021;10:e018304. [PMID: 33410332 DOI: 10.1161/JAHA.120.018304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thiele H, Jobs A. [ESC guidelines 2020: acute coronary syndrome without persistent ST-segment elevation : What is new?]. Herz 2021;46:3-13. [PMID: 33236199 DOI: 10.1007/s00059-020-05002-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xu Y, Shen Y, Chen D, Zhao P, Jiang J. Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis. J Interv Cardiol 2021;2021:9934535. [PMID: 34035674 DOI: 10.1155/2021/9934535] [Reference Citation Analysis]
5 Capodanno D, Bhatt DL, Gibson CM, James S, Kimura T, Mehran R, Rao SV, Steg PG, Urban P, Valgimigli M, Windecker S, Angiolillo DJ. Bleeding avoidance strategies in percutaneous coronary intervention. Nat Rev Cardiol 2021. [PMID: 34426673 DOI: 10.1038/s41569-021-00598-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang A, Liu J, Peng W, Jiang Y, Guo L, Xu Z. Application Analysis of Positive-Pressure Connector in Invasive Blood Pressure Monitoring in Coronary Interventional Therapy. Front Surg 2021;8:676310. [PMID: 34222318 DOI: 10.3389/fsurg.2021.676310] [Reference Citation Analysis]
7 Li Y, Li Y, Li B, Liu Y, Zhang J, Kuang W, Lu J, Cao Z, Cui J, Fan Z, Guo B, Li D. Antiplatelet Therapy with Integrated Traditional Chinese and Western Medicine for Use in Myocardial Ischemia-Reperfusion Injury: A Review of Clinical Applications and Mechanisms. Evid Based Complement Alternat Med 2021;2021:7409094. [PMID: 34335837 DOI: 10.1155/2021/7409094] [Reference Citation Analysis]
8 Kim L, Choe JC, Ahn JH, Lee HW, Oh JH, Choi JH, Lee HC, Cha KS, Hong TJ, Jeong YH, Park JS. Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial. J Clin Med 2021;10:1159. [PMID: 33802015 DOI: 10.3390/jcm10061159] [Reference Citation Analysis]
9 Bularga A, Meah MN, Doudesis D, Shah ASV, Mills NL, Newby DE, Lee KK. Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials. Open Heart 2021;8:e001707. [PMID: 34341097 DOI: 10.1136/openhrt-2021-001707] [Reference Citation Analysis]
10 Abraham MK, Jost E, Hohmann JD, Searle AK, Bongcaron V, Song Y, Wendel HP, Peter K, Krajewski S, Wang X. A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices. Pharmaceutics 2021;13:1504. [PMID: 34575580 DOI: 10.3390/pharmaceutics13091504] [Reference Citation Analysis]
11 Liang XY, Li Y, Qiao X, Zhang WJ, Wang ZL. Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Cardiovasc Med 2021;8:655718. [PMID: 34277725 DOI: 10.3389/fcvm.2021.655718] [Reference Citation Analysis]